abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume $13.10 -0.30 (-2.24%) Closing price 03:58 PM EasternExtended Trading$13.10 0.00 (0.00%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock abrdn Life Sciences Investors Short Interest Dataabrdn Life Sciences Investors (HQL) has a short interest of 76,700 shares, representing 0.30% of the float (the number of shares available for trading by the public). This marks a 70.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 108,007 shares to cover all short positions.Current Short Interest76,700 sharesPrevious Short Interest44,900 sharesChange Vs. Previous Month+70.82%Dollar Volume Sold Short$981.76 thousandShort Interest Ratio0.7 Days to CoverLast Record DateJune 30, 2025Outstanding Shares28,870,000 sharesShort Percent of Float0.30%Today's Trading Volume89,585 sharesAverage Trading Volume108,007 sharesToday's Volume Vs. Average83% Short Selling abrdn Life Sciences Investors? Sign up to receive the latest short interest report for abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHQL Short Interest Over TimeHQL Days to Cover Over TimeHQL Percentage of Float Shorted Over Time abrdn Life Sciences Investors Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202576,700 shares $981.76 thousand +70.8%0.3%0.7 $12.80 6/15/202544,900 shares $577.19 thousand +4.7%0.2%0.4 $12.86 5/31/202542,900 shares $526.38 thousand -17.3%0.2%0.4 $12.27 5/15/202551,900 shares $629.03 thousand +114.5%0.2%0.4 $12.12 4/30/202524,200 shares $310.24 thousand -78.4%N/A0.2 $12.82 4/15/2025111,800 shares $1.32 million +46.5%0.5%0.8 $11.81 3/31/202576,300 shares $966.72 thousand +26.3%0.3%0.6 $12.67 3/15/202560,400 shares $781.88 thousand -37.4%0.2%0.4 $12.95 2/28/202596,500 shares $1.30 million +94.6%0.4%0.7 $13.45 2/15/202549,600 shares $694.90 thousand +100.8%0.2%0.4 $14.01 Get the Latest News and Ratings for HQL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. 1/31/202524,700 shares $351.48 thousand -46.0%N/A0.2 $14.23 1/15/202545,700 shares $616.04 thousand -41.3%N/A0.4 $13.48 12/31/202477,800 shares $1.02 million +212.5%N/A0.8 $13.12 12/15/202424,900 shares $344.62 thousand -26.3%N/A0.3 $13.84 11/30/202433,800 shares $481.99 thousand -54.4%N/A0.4 $14.26 11/15/202474,100 shares $1.02 million +17.3%N/A1 $13.72 10/31/202463,200 shares $920.19 thousand +1.4%N/A1 $14.56 10/15/202462,300 shares $931.39 thousand -58.9%N/A0.9 $14.95 9/30/2024151,500 shares $2.28 million -1.7%N/A1.6 $15.07 9/15/2024154,100 shares $2.35 million -10.8%N/A1.6 $15.28 8/31/2024172,800 shares $2.61 million -22.0%N/A1.9 $15.13 8/15/2024221,500 shares $3.42 million -16.1%N/A2.4 $15.44 7/31/2024264,100 shares $4.06 million +4,978.9%N/A2.7 $15.37 7/15/20245,200 shares $79.46 thousand -67.7%N/A0.1 $15.28 6/30/202416,100 shares $228.14 thousand +67.7%N/A0.2 $14.17 6/15/20249,600 shares $132.67 thousand -72.4%N/A0.1 $13.82 5/31/202434,800 shares $463.54 thousand -52.7%N/A0.4 $13.32 5/15/202473,600 shares $1.05 million +26.0%N/A0.9 $14.27 4/30/202458,400 shares $765.62 thousand +205.8%N/A0.6 $13.11 4/15/202419,100 shares $247.92 thousand -10.3%N/A0.2 $12.98 3/31/202421,300 shares $290.32 thousand -27.6%N/A0.2 $13.63 3/15/202429,400 shares $396.90 thousand -47.5%N/A0.2 $13.50 2/29/202456,000 shares $767.20 thousand -58.0%N/A0.4 $13.70 2/15/2024133,400 shares $1.87 million +895.5%N/A1 $14.05 1/31/202413,400 shares $183.85 thousand -86.2%N/A0.1 $13.72 1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16 12/31/202370,700 shares $951.62 thousand +30.2%N/A0.5 $13.46 12/15/202354,300 shares $714.05 thousand +18.0%N/A0.4 $13.15 11/30/202346,000 shares $549.24 thousand -51.0%N/A0.4 $11.94 11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04"I'm risking my reputation on this" (Ad)Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.Claim your FREE copy of Crypto Revolution now. 10/31/202332,800 shares $380.15 thousand -42.9%N/A0.3 $11.59 10/15/202357,400 shares $704.87 thousand +71.9%N/A0.5 $12.28 9/30/202333,400 shares $416.50 thousand -7.2%N/A0.3 $12.47 9/15/202336,000 shares $461.88 thousand +40.1%N/A0.4 $12.83 8/31/202325,700 shares $334.36 thousand +71.3%N/A0.3 $13.01 8/15/202315,000 shares $201.30 thousand -63.0%N/A0.2 $13.42 7/31/202340,500 shares $544.73 thousand +282.1%N/A0.4 $13.45 7/15/202310,600 shares $142.15 thousand -85.7%N/A0.1 $13.41 6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55 6/15/20239,300 shares $128.71 thousand No ChangeN/A0.1 $13.84 5/31/20239,300 shares $123.60 thousand -76.6%N/A0.1 $13.29 5/15/202339,800 shares $559.59 thousand -27.2%N/A0.5 $14.06 4/30/202354,700 shares $761.97 thousand -2.0%N/A0.7 $13.93 4/15/202355,800 shares $782.87 thousand -1.8%N/A0.7 $14.03 3/31/202356,800 shares $791.22 thousand -45.8%N/A0.7 $13.93 3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72 2/28/202320,600 shares $287.58 thousand +186.1%N/A0.2 $13.96 2/15/20237,200 shares $105.34 thousand -22.6%N/A0.1 $14.63 1/31/20239,300 shares $138.94 thousand -17.7%N/A0.1 $14.94 1/15/202311,300 shares $166.79 thousand -50.9%N/A0.1 $14.76 12/30/202223,000 shares $326.83 thousand +62.0%N/A0.2 $14.21 12/15/202214,200 shares $209.02 thousand -10.7%N/A0.1 $14.72 11/30/202215,900 shares $239.77 thousand +28.2%N/A0.2 $15.08 11/15/202212,400 shares $186.62 thousand +7.8%N/A0.1 $15.05 10/31/202211,500 shares $168.48 thousand -62.9%N/A0.1 $14.65 10/15/202231,000 shares $427.49 thousand No ChangeN/A0.4 $13.79 9/30/202224,000 shares $327.84 thousand -33.9%N/A0.3 $13.66 9/15/202236,300 shares $537.24 thousand +80.6%N/A0.5 $14.80 8/31/202220,100 shares $290.24 thousand +55.8%N/A0.3 $14.44 8/15/202212,900 shares $210.40 thousand +79.2%N/A0.2 $16.31 7/31/20227,200 shares $107.42 thousand -77.1%N/A0.1 $14.92 7/15/202231,400 shares $475.08 thousand +91.5%N/A0.4 $15.13 6/30/202216,400 shares $233.37 thousand +11.6%N/A0.2 $14.23 6/15/202214,700 shares $198.16 thousand +110.0%N/A0.2 $13.48 5/31/20227,000 shares $101.99 thousand -84.6%N/A0.1 $14.57 5/15/202245,400 shares $653.76 thousand -30.5%N/A0.6 $14.40 4/30/202265,300 shares $1.01 million +262.8%N/A0.9 $15.49 4/15/202218,000 shares $303.66 thousand -1.1%N/A0.2 $16.87 3/31/202218,200 shares $301.03 thousand -55.6%N/A0.2 $16.54 3/15/202241,000 shares $637.55 thousand -67.6%N/A0.4 $15.55 2/28/2022126,600 shares $2.09 million -36.0%N/A1.4 $16.47 2/15/2022197,700 shares $3.48 million -18.6%N/A2.1 $17.61 1/31/2022243,000 shares $4.41 million +130.6%N/A2.8 $18.15 1/15/2022105,400 shares $1.96 million +626.9%N/A1.2 $18.56 12/31/202114,500 shares $278.84 thousand -85.8%N/A0.2 $19.23 12/15/2021102,200 shares $1.95 million -5.0%N/A1.5 $19.10 11/30/2021107,600 shares $2.13 million -29.9%N/A1.7 $19.84 11/15/2021153,400 shares $3.15 million -0.5%N/A2.5 $20.54 10/29/2021154,100 shares $3.28 million +553.0%N/A2.2 $21.27 10/15/202123,600 shares $487.58 thousand +34.9%N/A0.3 $20.66"I'm risking my reputation on this" (Ad)Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.Claim your FREE copy of Crypto Revolution now. 9/30/202117,500 shares $364 thousand -61.8%N/A0.3 $20.80 9/15/202145,800 shares $996.61 thousand +70.3%N/A0.7 $21.76 8/31/202126,900 shares $587.77 thousand -40.5%N/A0.4 $21.85 8/13/202145,200 shares $980.84 thousand +396.7%N/A0.6 $21.70 7/30/20219,100 shares $189.28 thousand +37.9%N/A0.1 $20.80 7/15/20216,600 shares $135.89 thousand -85.5%N/A0.1 $20.59 6/30/202145,500 shares $975.52 thousand +792.2%N/A0.6 $21.44 6/15/20215,100 shares $106.34 thousand -88.5%N/A0.1 $20.85 5/28/202144,400 shares $884.89 thousand -5.7%N/A0.5 $19.93 5/14/202147,100 shares $901.49 thousand -12.9%N/A0.5 $19.14 4/30/202154,100 shares $1.10 million +12.0%N/A0.6 $20.34 4/15/202148,300 shares $951.99 thousand -60.5%N/A0.6 $19.71 3/31/2021122,300 shares $2.39 million +38.7%N/A1.4 $19.51 3/15/202188,200 shares $1.78 million -23.8%N/A1.1 $20.23 2/26/2021115,700 shares $2.43 million +105.9%N/A1.4 $21.00 2/12/202156,200 shares $1.23 million +561.2%N/A0.7 $21.85 1/29/20218,500 shares $171.79 thousand -76.7%N/A0.1 $20.21 1/15/202136,400 shares $744.02 thousand -25.3%N/A0.5 $20.44 12/31/202048,700 shares $963.77 thousand +549.3%N/A0.6 $19.79 12/15/20207,500 shares $145.20 thousand -86.4%N/A0.1 $19.36 11/30/202055,000 shares $1.03 million +63.7%N/A0.7 $18.73 11/15/202033,600 shares $612.86 thousand -19.2%N/A0.4 $18.24 10/30/202041,600 shares $715.10 thousand +222.5%N/A0.5 $17.19 10/15/202012,900 shares $236.84 thousand -18.4%N/A0 $18.36 9/30/202015,800 shares $277.76 thousand -81.4%N/A0.2 $17.58 9/15/202011,000 shares $196.35 thousand -87.1%N/A0.1 $17.85 8/31/202085,000 shares $1.52 million +135.5%N/A1 $17.83 8/14/202036,100 shares $646.19 thousand -37.4%N/A0.4 $17.90 7/31/202057,700 shares $1.03 million +262.9%N/A0.6 $17.91 7/15/202015,900 shares $293.83 thousand +40.7%N/A0.2 $18.48 HQL Short Interest - Frequently Asked Questions What is abrdn Life Sciences Investors' current short interest? Short interest is the volume of abrdn Life Sciences Investors shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 76,700 shares of HQL short. 0.30% of abrdn Life Sciences Investors' shares are currently sold short. Learn More on abrdn Life Sciences Investors' current short interest. What is a good short interest ratio for abrdn Life Sciences Investors? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HQL shares currently have a short interest ratio of 1.0. Learn More on abrdn Life Sciences Investors's short interest ratio. What is a good short interest percentage for abrdn Life Sciences Investors? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of abrdn Life Sciences Investors' floating shares are currently sold short. Is abrdn Life Sciences Investors' short interest increasing or decreasing? abrdn Life Sciences Investors saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 76,700 shares, an increase of 70.8% from the previous total of 44,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does abrdn Life Sciences Investors' short interest compare to its competitors? 0.30% of abrdn Life Sciences Investors' shares are currently sold short. Here is how the short interest of companies in the industry of "financial services" compare to abrdn Life Sciences Investors: Goldman Sachs BDC, Inc. (2.07%), MidCap Financial Investment Corporation (0.73%), New Mountain Finance Corporation (1.84%), PennantPark Floating Rate Capital Ltd. (0.93%), Bain Capital Specialty Finance, Inc. (0.37%), Barings Bdc, Inc. (0.44%), AllianceBernstein Global High Income Fund, Inc. (0.17%), abrdn Healthcare Investors (0.10%), PIMCO High Income Fund (0.26%), Carlyle Secured Lending, Inc. (1.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short abrdn Life Sciences Investors stock? Short selling HQL is an investing strategy that aims to generate trading profit from abrdn Life Sciences Investors as its price is falling. HQL shares are trading down $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against abrdn Life Sciences Investors? A short squeeze for abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further. How often is abrdn Life Sciences Investors' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Goldman Sachs BDC Short Interest Data MidCap Financial Investment Short Interest Data New Mountain Finance Short Interest Data PennantPark Floating Rate Capital Short Interest Data Bain Capital Specialty Finance Short Interest Data Barings Bdc Short Interest Data AllianceBernstein Global High Income Fund Short Interest Data abrdn Healthcare Investors Short Interest Data PIMCO High Income Fund Short Interest Data Carlyle Secured Lending Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HQL) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
